Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Regeneron Pharmaceuticals Inc (REGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
855.400 +4.000    +0.47%
15/04 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 1
  • Bid/Ask: 843.200 / 847.600
  • Day's Range: 846.400 - 855.400
Type:  Equity
Market:  Germany
ISIN:  US75886F1075 
S/N:  881535
Regeneron Pharma 855.400 +4.000 +0.47%

NASDAQ:REGN Financials

 
This summary provides an overview of the most significant critical numbers from each of the Regeneron financial reports, including theRegeneron Pharmaceuticals Inc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NASDAQ:REGN financials over time via breakdowns of their annual reports.

Regeneron Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 13,117.2 million compared to USD 12,172.9 million a year ago. Net income was USD 3,953.6 million compared to USD 4,338.4 million a year ago. Basic earnings per share from continuing operations was USD 37.05 compared to USD 40.51 a year ago. Diluted earnings per share from continuing operations was USD 34.77 compared to USD 38.22 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

REGN Income Statement & Profits

Gross margin TTM 52.32%
Operating margin TTM 32.27%
Net Profit margin TTM 30.14%
Return on Investment TTM 14.06%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 3434.3 3362.7 3158.1 3162.1
Gross Profit 1754.6 1851 1667.9 1603.4
Operating Income 1050.7 1211 1016.5 1002.8
Net Income 1159.6 1007.8 968.4 817.8

REGN Balance Sheet

Quick Ratio MRQ 4.72
Current Ratio MRQ 5.69
LT Debt to Equity MRQ 7.63%
Total Debt to Equity MRQ 10.74%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 33080.2 32163.3 30657.5 30059.9
Total Liabilities 7107.1 7258.9 6639.6 6564.7
Total Equity 25973.1 24904.4 24017.9 23495.2

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 43.2
Revenue/Share TTM 123.34
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 1114.3 1022.4 1367.6
Cash From Investing Activities -496.3 -2386.9 -235.7
Cash From Financing Activities -407.3 -614.2 -322.5
Net Change in Cash 210.5 -1979.1 809.4
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

REGN Price Commentary

Write your thoughts about Regeneron Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Manju Singh
Manju Singh Dec 21, 2021 15:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Profit taking
CJ Refalo
CJ Refalo Mar 23, 2021 19:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is the worst stock I had ever invested in. it just keeps going down and down with no bottom in sight. what a disgrace.
Hasantha Palihakkara
Hasantha Palihakkara Mar 23, 2021 19:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Me too
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email